Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

What do we know about palmoplantar pustulosis?
Magdalena Misiak-Gałązka, Hanna Wolska, Lidia Rudnicka
Journal of the European Academy of Dermatology and Venereology (2016) Vol. 31, Iss. 1, pp. 38-44
Closed Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Generalized pustular psoriasis: a review and update on treatment
Karl M. Hoegler, A.M. John, Marc Z. Handler, et al.
Journal of the European Academy of Dermatology and Venereology (2018) Vol. 32, Iss. 10, pp. 1645-1651
Closed Access | Times Cited: 174
Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study
Ulrich Mrowietz, H. Bachelez, A. David Burden, et al.
Journal of the American Academy of Dermatology (2019) Vol. 80, Iss. 5, pp. 1344-1352
Open Access | Times Cited: 123
Nail psoriasis: clinical features, pathogenesis, differential diagnoses, and management
Eckart Haneke
Psoriasis Targets and Therapy (2017) Vol. Volume 7, pp. 51-63
Open Access | Times Cited: 101
Pathogenesis, multi-omics research, and clinical treatment of psoriasis
Jiadong Yu, Qixiang Zhao, Xiaoyan Wang, et al.
Journal of Autoimmunity (2022) Vol. 133, pp. 102916-102916
Closed Access | Times Cited: 58
Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis and non‐pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER‐1, UNCOVER‐2 and UNCOVER‐3)
Alan Menter, Richard B. Warren, Richard Langley, et al.
Journal of the European Academy of Dermatology and Venereology (2017) Vol. 31, Iss. 10, pp. 1686-1692
Open Access | Times Cited: 71
Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial
Yukari Okubo, Satomi Kobayashi, Masamoto Murakami, et al.
American Journal of Clinical Dermatology (2024)
Open Access | Times Cited: 7
Autoinflammatory Disorders: A Review and Update on Pathogenesis and Treatment
Annika Havnaer, George Han
American Journal of Clinical Dermatology (2019) Vol. 20, Iss. 4, pp. 539-564
Closed Access | Times Cited: 52
Pathogenesis of psoriasis in the “omic” era. Part II. Genetic, genomic and epigenetic changes in psoriasis
Bogusław Nedoszytko, Aneta Szczerkowska‐Dobosz, Marta Stawczyk‐Macieja, et al.
Advances in Dermatology and Allergology (2020) Vol. 37, Iss. 3, pp. 283-298
Open Access | Times Cited: 43
Similarity and difference between palmoplantar pustulosis and pustular psoriasis
Toshiyuki Yamamoto
The Journal of Dermatology (2021) Vol. 48, Iss. 6, pp. 750-760
Closed Access | Times Cited: 36
Characteristics and Burdens of Disease in Patients from Beijing with Generalized Pustular Psoriasis and Palmoplantar Pustulosis: Multicenter Retrospective Cohort Study Using a Regional Database
Hai-Meng Wang, Jiaming Xu, Hongzhong Jin
American Journal of Clinical Dermatology (2023) Vol. 24, Iss. 6, pp. 991-1002
Closed Access | Times Cited: 11
Clinical Characteristics of Japanese Patients with Palmoplantar Pustulosis
Toshiyuki Yamamoto
Clinical Drug Investigation (2019) Vol. 39, Iss. 3, pp. 241-252
Closed Access | Times Cited: 30
Diagnostic histopathological features distinguishing palmoplantar pustulosis from pompholyx
Kana Masuda‐Kuroki, Masamoto Murakami, Mari Kishibe, et al.
The Journal of Dermatology (2019) Vol. 46, Iss. 5, pp. 399-408
Open Access | Times Cited: 30
Economic burden of generalized pustular psoriasis and palmoplantar pustulosis in the United States
Maya Hanna, David Singer, Wendell C. Valdecantos
Current Medical Research and Opinion (2021) Vol. 37, Iss. 5, pp. 735-742
Closed Access | Times Cited: 27
What Is New and What Is Next for SAPHO Syndrome Management: A Narrative Review
Mario Ferraioli, Juela Levani, Riccardo De Luca, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1366-1366
Open Access
Increased levels of lipocalin 2 in palmoplantar pustular psoriasis
Kerstin Wolk, Yvonne Frambach, Arnd Jacobi, et al.
Journal of Dermatological Science (2018) Vol. 90, Iss. 1, pp. 68-74
Closed Access | Times Cited: 29
Risks of Comorbidities in Patients With Palmoplantar Pustulosis vs Patients With Psoriasis Vulgaris or Pompholyx in Korea
Dong Hyo Kim, Jin Yong Lee, Soo Ick Cho, et al.
JAMA Dermatology (2022) Vol. 158, Iss. 6, pp. 650-650
Open Access | Times Cited: 15
Interleukin (IL)-8 and IL-36γ but not IL-36Ra are related to acrosyringia in pustule formation associated with palmoplantar pustulosis
Xiaoling Yu, Wei Chao, W. Wenming, et al.
Clinical and Experimental Dermatology (2018) Vol. 44, Iss. 1, pp. 52-57
Open Access | Times Cited: 27
Comparison of the Inflammatory Circuits in Psoriasis Vulgaris, Non‒Pustular Palmoplantar Psoriasis, and Palmoplantar Pustular Psoriasis
Claire Q. Wang, Sokol Haxhinasto, Sandra Garcet, et al.
Journal of Investigative Dermatology (2022) Vol. 143, Iss. 1, pp. 87-97.e14
Open Access | Times Cited: 13
Associations of inflammatory cytokines with palmoplantar pustulosis: a bidirectional Mendelian randomization study
Chengling Liu, Xingchen Liu, Haiming Xin, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 2
Psoriasis and palmoplantar pustulosis: an endless debate?
Alexandra Maria Giovanna Brunasso, Cesare Massone
Journal of the European Academy of Dermatology and Venereology (2017) Vol. 31, Iss. 7
Closed Access | Times Cited: 21
How frequently does palmoplantar psoriasis affect the palms and/or soles? A systematic review and meta-analysis
Zorica Sojević Timotijević, Goran Trajković, Janko Janković, et al.
Advances in Dermatology and Allergology (2019) Vol. 36, Iss. 5, pp. 595-603
Open Access | Times Cited: 18
The Epidemiology of Palmoplantar Pustulosis: An Analysis of Multiple Health Insurance Claims and Electronic Health Records Databases
Darmendra Ramcharran, Bruce Strober, Kenneth B. Gordon, et al.
Advances in Therapy (2023) Vol. 40, Iss. 11, pp. 5090-5101
Open Access | Times Cited: 6
The microbiome of the “sterile” pustules in palmoplantar pustulosis
Kana Masuda‐Kuroki, Masamoto Murakami, Naohito Tokunaga, et al.
Experimental Dermatology (2018) Vol. 27, Iss. 12, pp. 1372-1377
Closed Access | Times Cited: 17
Guselkumab for the treatment of palmoplantar pustulosis
Masamoto Murakami
Expert Opinion on Biological Therapy (2020) Vol. 20, Iss. 8, pp. 841-852
Closed Access | Times Cited: 15
Optimal treatments and outcome measures of palmoplantar pustulosis: A systematic review and network meta‐analysis‐based comparison of treatment efficacy
Takemichi Fukasawa, Takashi Yamashita, Atsushi Enomoto, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 2, pp. 281-288
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top